Counteracting progression of renal disease: A look into the future

Kidney International, Supplement

Volumn 57, Issue 75, 2000, Pages

  Ritz, Eberhard ^a   Schömig, Michael ^a   Wagner, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Glomerulosclerosis; Interstitial fibrosis; Progression; Renal failure; Renal transplantation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MOXONIDINE; RENIN;

CONFERENCE PAPER; DISEASE COURSE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; FORECASTING; KIDNEY TRANSPLANTATION; REVIEW;

DISEASE PROGRESSION; FORECASTING; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION;

EID: 0343729523     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07513.x     Document Type: Conference Paper

References (42)

1. KELLER C, RITZ E, POMMER W, STEIN G, FRANK J, SCHWARZBECK A: Behandlungsqualität niereninsuffizienter Diabetiker in Deutschland. Dtsch Med Wochenschr, in press
2. ORTH SR, RITZ E, SCHRIER RW: The renal risk of smoking. Kidney Int 51:1669-1677, 1997
3. HÜLLINGHORST R (Ed.): Jahrbuch Sucht. Geesthacht, Neuland Verlag, 1996
4. THE DIABETES CONTKOL AND COMPLICATIONS TRIALS RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. OHKUBO Y, KISHIKAWA H, ARAKI E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6 year study. Diabetes Res 28:103-117, 1995
6. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
7. ISMAIL N, BECKER B, STRZELCZYK P, RITZ E: Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 55:1-28, 1999
8. RITZ E, RYCHLIK I, LOCATELLI F, HALIMI S: End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808, 1999
9. RITZ E, ORTH SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127-1133, 1999
10. PLATA R, SILVA C, YAHUITA J, PEREZ L, SCHIEPPATI A, REMUZZI G: The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant 13:3034-3036, 1998
11. BROWN DM, PROVOOST AP, DELY MJ, LANDER ES, JACOB HT: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 12(1):44-51, 1996
12. RAMBAUSEK M, HARTZ G, WALDHERR R, ANDRASSY K, RITZ E: Familial glomerulonephritis. Pediatr Nephrol 1:416-418, 1987
13. SEAQUIST ER, GOTZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
14. PETTITT KF, SAAD MF, BENNETT PH, NELSON RG, KNOWLER WC: Familial predisposition to renal disease in two generation of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-442, 1990
15. STROJEK K, GRZESZCZAK W, MORAWIN E, ADAMSKI M, LACKA B, RUDZKI H, RITZ E: Nephropathy of type 2 diabetes: evidence for hereditary factors? Kidney Int 51:1602-1607, 1997
16. SMADEL JE: Experimental nephritis in rats induced by injection of anti-kidney serum. J Exp Med 65:541-555, 1939
17. VOLHARD F: Die doppelseitigen hämatogenen Nierenerkrankungen. In: Handbuch der Inneren Medizin, edited by BERGMANN G, STAEHELIN R, Berlin, Julius Springer, 1931
18. BRENNER BM, MEYER TW, HOSTETTER TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular scleroses in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
19. HOSTETTER TH, OLSON JL, RENNKE HG, VENKATACHALAM MA, BRENNER BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:85-93, 1981
20. REMUZZI G, BERTANI T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384-394, 1990
21. MÜLLER GA, SCHETTLER V, MÜLLER CA, STRUTZ F: Prevention of progression of renal fibrosis: how far are we? Kidney Int 49 (Suppl 54):S-75-S-82, 1996
22. PRICE D, PORTER LE, GORDON M, FISHER NDL, DE'OLIVEIRA JMF, LAFFEL LMB, PASSAN DR, WILLIAMS GH, HOLLENBERG NK: The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10:2382-2391, 1999
23. WAGNER J, GEHLEN F, CIECHANOWICZ A, RITZ E: Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. J Am Soc Nephrol 10:545-551, 1999
24. REMUZZI G, BEKTANI T: Pathophysiology of progressive nephropathies. N Engl J Mal 339:1448-1456, 1998
25. PETERS H, NOBLE NA, BORDER WA: Targeting TGF-beta over-expression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54:1575-1583, 1998
26. PETERS H, RITZ E: Dosing angiotensin II blockers - Beyond blood pressure. Nephrol Dial Transplant 14:2568-2570, 1999
27. BENIGNI A, ZOJA C, CORNA D, ORISIO S, LONGARETTI L, BERTANI T, REMUZZI G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44:440-444, 1993
28. NABAKOV A, AMANN K, WAGNER J, GEHLEN F, MÜNTER K, RITZ E: Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol Dial Transplant 11:514-520, 1996
29. ORTH SR, ODONI G, AMANN K, STRZELCZYK P, RASCHACK M, RITZ E: The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model. J Am Soc Nephrol 10:387-391, 1999
30. BENIGNI A, REMUZZI G: Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking? Nephrol Dial Transplant 13:2734-2738, 1998
31. AMANN K, RUMP LC, SIMONAVICIENE A, OBERHAUSER V, WESSELS S, ORTH SR, GROSS ML, BIELENBERG GW, VAN KATS JP, EHMKE H, MALI G, RITZ E: Effects of sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol, in press.
32. COGGINS CH, BREYER LEWIS J, CAGGIULA AW, CASTALDO LS, KLAHR S, WANG SR: Differences between women and men with chronic renal disease. Nephrol Dial Transplant 13:1430-1437, 1998
33. ZEIER M, GAFTER U, RITZ E: Renal function and renal disease in males or females - Vive la petite difference. Nephrol Dial Transplant 13:2195-2198, 1998
34. MERVAALA EM, MÜLLER DN, PARK JK, SCHMIDT F, LOHN M, BREU V, DRAGUN D, GANTEN D, HALLER H, LUFT FC: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 33:389-395, 1999
35. FLOEGE J, OSTENDORF T, JANJIÉ N: Aptamers: Novel tools for specific intervention studies. Nephrol Dial Transplant 14:1354-1357, 1999
36. OPELZ G, WUJCTAK T, RITZ E: Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217-222, 1998
37. LINDHOLM A, ALBRECHTSKN D, FRÖDIN L, TUFVESON G, PERSSON NH, LUNDGREN G: Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451-457, 1995
38. COSIO FG, PELLETIER RP, SEDMAK DD, PEAVENTO TE, HENRY ML, FERGUSON RM: Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology. Kidney Int 56:1912-1919, 1999
39. MOURLON-LF GRAND MC, POTTEVIN P, BENESSIANO J, DURIEZ M, MICHEL JB, LEVY BI: Effect of a nonhypotensive long-term infusion of ANP on the mechanical and structural properties of the arterial wall in Wistar-Kyoto and spontaneously hypertensive rats. Arteriosl Thromb 13:640-650, 1993
40. HAUSBERG M, BARENBROCK M, HOHAGE H, MÜLLER S, HEIDENREICH S, RAHN KH: ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 33:862-868, 1999
41. FELLSTRÖM B, BACKMAN U, LARSSON E, ZEZINA L: Immunologic and nonimmunologic risk factors of chronic rejection. Transplant Proc 31:1304-1305, 1993
42. BÜCHNER L: Am Sterbelager des Jahrhunderts. Blicke eines freien Denkers aus der Zeit in die Zeit. Roth, Gießen, 1900